ECSP024293A - 13-RETINOIC CIS IN PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION - Google Patents

13-RETINOIC CIS IN PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION

Info

Publication number
ECSP024293A
ECSP024293A ECSP024293A ECSP024293A EC SP024293 A ECSP024293 A EC SP024293A EC SP024293 A ECSP024293 A EC SP024293A EC SP024293 A ECSP024293 A EC SP024293A
Authority
EC
Ecuador
Prior art keywords
pharmaceutical composition
cis
retinoic
oral administration
emulsion
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Beleno Alfredo Berthel
De La Ossa Jorge Gomez
Original Assignee
Procaps S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procaps S A filed Critical Procaps S A
Priority to ECSP024293 priority Critical patent/ECSP024293A/en
Priority to PE2003000714A priority patent/PE20040127A1/en
Priority to CO03062767A priority patent/CO5360643A1/en
Publication of ECSP024293A publication Critical patent/ECSP024293A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describe un proceso mejorado para composición farmacéutica y su formulación en emulsión de 13-cis retinoico para aplicación oral sistemática. El proceso permite obtener una emulsión a través de la utilización de fuerza centrifuga estable para composiciones y formas de dosificación unitaria útil en terapia.An improved process for pharmaceutical composition and its emulsion formulation of 13-cis retinoic acid for systematic oral application is described. The process allows an emulsion to be obtained through the use of stable centrifugal force for compositions and unit dosage forms useful in therapy.

ECSP024293 2002-07-26 2002-07-26 13-RETINOIC CIS IN PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION ECSP024293A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ECSP024293 ECSP024293A (en) 2002-07-26 2002-07-26 13-RETINOIC CIS IN PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
PE2003000714A PE20040127A1 (en) 2002-07-26 2003-07-17 IMPROVED PROCESS FOR 13-CIS RETINOIC ACID IN PHARMACEUTICAL COMPOSITION FOR PHARMACEUTICAL ADMINISTRATION FOR ORAL SYSTEMIC ADMINISTRATION
CO03062767A CO5360643A1 (en) 2002-07-26 2003-07-24 PROCESS FOR THE FORMULATION OF ISOTRETINOIN IN EMULSION AND PHARMACEUTICAL COMPOSITIONS OBTAINED BY MEANS OF THIS PROCESS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP024293 ECSP024293A (en) 2002-07-26 2002-07-26 13-RETINOIC CIS IN PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION

Publications (1)

Publication Number Publication Date
ECSP024293A true ECSP024293A (en) 2004-02-26

Family

ID=40435075

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP024293 ECSP024293A (en) 2002-07-26 2002-07-26 13-RETINOIC CIS IN PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION

Country Status (3)

Country Link
CO (1) CO5360643A1 (en)
EC (1) ECSP024293A (en)
PE (1) PE20040127A1 (en)

Also Published As

Publication number Publication date
PE20040127A1 (en) 2004-06-01
CO5360643A1 (en) 2004-01-30

Similar Documents

Publication Publication Date Title
CL2019000209A1 (en) Novel orally administrable formulation.
HRP20060147B1 (en) CONTROLLED RELEASE THERAPY SYSTEM FOR Oral Use
AR048878A1 (en) TOPIC COMPOSITIONS OF METADONA AND METHODS FOR USE
DE602006014990D1 (en) INTRANASAL ADMINISTRATION OF FAST-ACTING INSULIN
NZ594618A (en) Transdermal pharmaceutical preparations
CY1112256T1 (en) PHARMACEUTICAL DOSAGE FORMING CONTAINERS AND METHOD OF PREPARATION
WO2003028757A1 (en) Novel method of inducing antigen-specific t cells
ATE362750T1 (en) COSMETIC PRODUCT FORMULATION KIT
AU2002231654A1 (en) Pharmaceutical paste comprising an acid-labile active ingredient
AR034813A1 (en) PHARMACEUTICAL COMPOSITIONS AND USE OF THE SAME
DOP2002000389A (en) METHOD FOR MANUFACTURING A PHARMACEUTICAL COMPOSITION OF LOW DOSE THAT HAS A DISTRIBUTION AND POWER OF THE UNIFORM DRUG
BRPI0513622A (en) application of self-emulsifying combinations (seeds) of lipid excipients, surfactants; pharmaceutical composition containing an active ingredient and a self-emulsifying combination (seeds) of lipid excipients, surfactants; and process for the preparation of self-emulsifying combinations (seeds) of lipid excipients, surfactants
AR047191A1 (en) METHODS OF TREATMENT OF HEPATIC FIBROSIS
BR0315927A (en) Single dose daily melatonin units
AR048050A1 (en) MASTICABLE, NON-COMPRESSED, METHODS OF ADMINISTRATION INDIVIDUALLY DOSED
AR045719A1 (en) PHARMACEUTICAL FORMULATION THAT INCLUDES SODIUM LEVOTIROXIN, MICROCRYSTALLINE CELLULOSE AND PREGELATINIZED ALMIDON; USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND PROCESS TO PREPARE THIS FORMULATION
ATE427737T1 (en) MICROEMULSIONS OF RETINOIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
PE20030830A1 (en) AMBROXOL FOR THE TREATMENT OF PAINFUL STATES IN THE ORAL CAVITY AND PHARYNGEAL
EA200702102A1 (en) PLATES CONTAINING STEROID HORMONES
EA200701923A1 (en) DRUG FORM FOR THE ORAL ADMINISTRATION OF VITAMIN
ATE410152T1 (en) THERAPEUTIC SYSTEM WITH AMOXICILLIN AND CLAVULANIC ACID
ECSP024293A (en) 13-RETINOIC CIS IN PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
AR043370A1 (en) PHARMACEUTICAL COMPOSITIONS OF ORAL ADMINISTRATION AND METHODS TO AVOID FOOD-DRUG INTERACTION
CR8059A (en) PHARMACEUTICAL COMPOSITION IN THE FORM OF HYDROGEL FOR TRANSDERMAL ADMINISTRATION OF ACTIVE SUBSTANCES
AR086491A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING FEXOFENADINE